Clinical Trial: Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Osteonecrosis Due to Drugs, Jaw
Study Type: Interventional
Official Title: Benefit of Cryopreserved Human Amniotic Membrane (hAM) on Oral Mucosal Healing Among Patients With Stage II Maxillomandibular Osteonecrosis Induced by Antiresorptive and/or Anti-angiogenic Therapies:
Brief Summary:
This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.
Read more